Us Bancorp \De\ Regeneron Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 4,988 shares of REGN stock, worth $3.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,988

Previous 5,163 3.39%

Holding current value

$3.69 Million

Previous $5.43 Million 3.37%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$1024.09 - $1201.76 $179,215 - $210,308	-175 Reduced 3.39%	4,988 $5.24 Million
Q2 2024 Aug 06, 2024	BUY	$883.2 - $1071.19 $135,129 - $163,892	153 Added 3.05%	5,163 $5.43 Million
Q1 2024 May 07, 2024	BUY	$902.69 - $993.35 $62,285 - $68,541	69 Added 1.4%	5,010 $4.82 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $240,305 - $273,327	310 Added 6.69%	4,941 $4.34 Million
Q3 2023 Nov 03, 2023	BUY	$692.45 - $844.37 $40,854 - $49,817	59 Added 1.29%	4,631 $3.81 Million
Q2 2023 Aug 09, 2023	SELL	$700.03 - $830.35 $375,216 - $445,067	-536 Reduced 10.49%	4,572 $3.29 Million
Q1 2023 May 09, 2023	BUY	$680.49 - $826.97 $114,322 - $138,930	168 Added 3.4%	5,108 $4.2 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $595,065 - $646,066	-843 Reduced 14.58%	4,940 $3.56 Million
Q3 2022 Oct 27, 2022	BUY	$573.97 - $724.32 $42,473 - $53,599	74 Added 1.3%	5,783 $3.98 Million
Q2 2022 Aug 01, 2022	SELL	$548.35 - $738.84 $158,473 - $213,524	-289 Reduced 4.82%	5,709 $3.38 Million
Q1 2022 May 11, 2022	BUY	$595.12 - $698.43 $22,019 - $25,841	37 Added 0.62%	5,998 $4.19 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $20,108 - $24,825	37 Added 0.62%	5,961 $3.77 Million
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $107,343 - $127,339	-187 Reduced 3.06%	5,924 $3.59 Million
Q2 2021 Aug 05, 2021	BUY	$472.8 - $558.54 $43,970 - $51,944	93 Added 1.55%	6,111 $3.41 Million
Q1 2021 Apr 28, 2021	BUY	$446.73 - $548.2 $279,652 - $343,173	626 Added 11.61%	6,018 $2.85 Million
Q4 2020 Feb 04, 2021	BUY	$478.3 - $607.98 $397,467 - $505,231	831 Added 18.22%	5,392 $2.61 Million
Q3 2020 Nov 10, 2020	BUY	$544.75 - $658.21 $709,264 - $856,989	1,302 Added 39.95%	4,561 $2.55 Million
Q2 2020 Aug 07, 2020	SELL	$493.32 - $643.92 $124,316 - $162,267	-252 Reduced 7.18%	3,259 $2.03 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $80,347 - $118,168	-239 Reduced 6.37%	3,511 $1.71 Million
Q4 2019 Feb 04, 2020	BUY	$274.13 - $376.51 $25,768 - $35,391	94 Added 2.57%	3,750 $1.41 Million
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $17,501 - $20,376	-64 Reduced 1.72%	3,656 $1.01 Million
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $515,012 - $713,075	-1,719 Reduced 31.61%	3,720 $1.16 Million
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $4,837 - $5,714	13 Added 0.24%	5,439 $2.23 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $207,200 - $248,675	-617 Reduced 10.21%	5,426 $2.03 Million
Q3 2018 Nov 01, 2018	BUY	$351.14 - $408.51 $23,175 - $26,961	66 Added 1.1%	6,043 $2.44 Million
Q2 2018 Aug 08, 2018	SELL	$284.6 - $344.99 $91,072 - $110,396	-320 Reduced 5.08%	5,977 $2.06 Million
Q1 2018 May 08, 2018	BUY	$315.82 - $393.78 $42,004 - $52,372	133 Added 2.16%	6,297 $2.17 Million
Q4 2017 Feb 02, 2018	BUY	$358.63 - $469.95 $214,819 - $281,500	599 Added 10.76%	6,164 $2.32 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $2.4 Million - $2.8 Million	5,565	5,565 $2.49 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account